Background Subarachnoid hemorrhage (SAH) results from extravasation of blood into the subarachnoid space and is associated with high morbidity and mortality. This study aimed to compare systolic blood pressure variability (SBPV) and intracranial pressure variability (ICPV) in three 8-hour intervals during the first 24 hours after hospital admission and investigate their associations with discharge disposition and in-hospital mortality.
Methods We retrospectively reviewed charts of adult patients with spontaneous, non-traumatic SAH admitted for at least 24 hours from 2016-2020. Hourly measurements were recorded for both systolic blood pressure (SBP) and intracranial pressure (ICP), and SBPV and ICPV were measured using successive variation (SV) and standard deviation (SD).
Results A total of 240 patients were included (mean age 57±14.2 years, 64.6% female); 40 (16.7%) died. In the first 8-hour interval, higher SBP-SV (22.7±13.8) was significantly associated with mortality (p=0.028) and not being discharged home (p=0.022), compared to those who survived (17.6±7.5) or were discharged home (16.7±5.5). No significant differences in ICPV emerged for mortality or disposition, though higher ICP-SV in the first 8 hours approached significance (p=0.054) for discharge disposition. Receiver operating curve analysis showed poor discrimination for the first 8-hour SBP-SV (area under the curve 0.62) and failure for ICP-SV (0.51) in predicting mortality.
Conclusions Greater SBP variability in the first 8 hours was linked to poorer outcomes, underscoring the potential importance of stabilizing blood pressure in this critical window. No clear association was observed between ICP variability and outcomes.
Competing Interest StatementThe authors have declared no competing interest.
Funding StatementThis study did not receive any funding
Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the University of Maryland Baltimore IRB (HP-00084554)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
FootnotesJane.Quackenbushsom.umaryland.edu
jolexasom.umaryland.edu
kimay00gmail.com
ylin1216terpmail.umd.edu
drscard013gmail.com
qtransom.umaryland.edu
# Co-Senior Authors
↵Conflict of Interest: There were no conflicts of interest while creating this manuscript. The authors received no funding from any external or internal sources for the work of this manuscript.
Data AvailabilityAll data produced in the present study are available upon reasonable request to the authors
Comments (0)